Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC): Results From a Phase 2, Placebo-Controlled Study (GO27821) Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Wakelee, H. A., Zvirbule, Z., De Braud, F., Kingsley, C. D., Mekhail, T., Schuette, W., Lena, H., Lawler, W., Braiteh, F., Cosgriff, T., Kaen, D., Boyer, M., Hsu, J., Phan, S., Novello, S.

authors

Publication Date

  • November 15, 2014

webpage

published in

category

start page

  • S37

end page

  • S38

volume

  • 90

WoS Citations

  • 2

WoS References

  • 0